Transcriptomic analysis performed on prostate [12], liver [13], and colon [14] cancers also identified unique gene expression profiles for NAT, resulting from a crosstalk between tumor and adjacent tissue, principally mediated by cytokines and other tumor-secreted factors. The gene discussed is BRD2; the disease is cancer.